120 related articles for article (PubMed ID: 15064931)
21. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
22. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
23. Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
Shehadeh NJ; Ensley JF; Kucuk O; Black C; Yoo GH; Jacobs J; Lin HS; Heilbrun LK; Smith D; Kim H
Head Neck; 2006 Dec; 28(12):1090-8. PubMed ID: 16933316
[TBL] [Abstract][Full Text] [Related]
24. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
[TBL] [Abstract][Full Text] [Related]
25. The role of peptide growth factors in head and neck carcinoma.
Grandis JR; Tweardy DJ
Otolaryngol Clin North Am; 1992 Oct; 25(5):1105-15. PubMed ID: 1408194
[TBL] [Abstract][Full Text] [Related]
26. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
27. The effect of neck dissection on quality of life after chemoradiation.
Donatelli-Lassig AA; Duffy SA; Fowler KE; Ronis DL; Chepeha DB; Terrell JE
Otolaryngol Head Neck Surg; 2008 Oct; 139(4):511-8. PubMed ID: 18922336
[TBL] [Abstract][Full Text] [Related]
28. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
30. Targeted therapy: A novel approach in head and neck cancer.
Christy AW; Bojan A
Indian J Dent Res; 2013; 24(2):261-6. PubMed ID: 23965459
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.
Curran D; Giralt J; Harari PM; Ang KK; Cohen RB; Kies MS; Jassem J; Baselga J; Rowinsky EK; Amellal N; Comte S; Bonner JA
J Clin Oncol; 2007 Jun; 25(16):2191-7. PubMed ID: 17538164
[TBL] [Abstract][Full Text] [Related]
32. The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.
Aarstad HJ; Aarstad AK; Lybak S; Monge O; Haugen DF; Olofsson J
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):9-15. PubMed ID: 16205902
[TBL] [Abstract][Full Text] [Related]
33. Analysis of prognostic factors in squamous cell carcinomas of the head and neck.
Dreyfuss AI; Clark JR
Hematol Oncol Clin North Am; 1991 Aug; 5(4):701-12. PubMed ID: 1890061
[TBL] [Abstract][Full Text] [Related]
34. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
35. The role of folates in squamous cell carcinoma of the head and neck.
Kane MA
Cancer Detect Prev; 2005; 29(1):46-53. PubMed ID: 15734217
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in head and neck cancer survivors: a cross-sectional survey.
Chaukar DA; Walvekar RR; Das AK; Deshpande MS; Pai PS; Chaturvedi P; Kakade A; D'Cruz AK
Am J Otolaryngol; 2009; 30(3):176-80. PubMed ID: 19410123
[TBL] [Abstract][Full Text] [Related]
37. Suicide: A Major Threat to Head and Neck Cancer Survivorship.
Osazuwa-Peters N; Adjei Boakye E; Walker RJ; Varvares MA
J Clin Oncol; 2016 Apr; 34(10):1151. PubMed ID: 26786926
[No Abstract] [Full Text] [Related]
38. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.
Loose D; Signore A; Bonanno E; Vermeersch H; Dierckx R; Deron P; Van de Wiele C
Cancer Biother Radiopharm; 2008 Feb; 23(1):25-33. PubMed ID: 18298326
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor/scatter factor stimulates mitogenesis and migration of a head and neck squamous cell carcinoma cell line.
Fleigel J; Sedwick J; Kornberg LJ
Otolaryngol Head Neck Surg; 2002 Oct; 127(4):271-8. PubMed ID: 12402004
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in head and neck cancer.
Haddad RI; Shin DM
N Engl J Med; 2008 Sep; 359(11):1143-54. PubMed ID: 18784104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
